New DCGI likely to be announced soon, Dr VG Somani among top contenders
New Delhi: The Union Public Service Commission (UPSC) conducted interviews for the Drugs Controller General of India (DCGI) appointment this week.The top contenders are Dr VG Somani, Dr Rajeev Singh Raghuvanshi and Dr Jai Prakash. According to the sources soon final name will be announced.Earlier on November 16 last year, the tenure of Dr VG Somani the DCGI was extended by three months for...
Login or Register to read the full article
New Delhi: The Union Public Service Commission (UPSC) conducted interviews for the Drugs Controller General of India (DCGI) appointment this week.
The top contenders are Dr VG Somani, Dr Rajeev Singh Raghuvanshi and Dr Jai Prakash. According to the sources soon final name will be announced.
Earlier on November 16 last year, the tenure of Dr VG Somani the DCGI was extended by three months for the second time. Somani also got an extension in the month of August 2022.
Dr Somani was appointed DCGI for a term of three years on August 14, 2019.
Dr Kiran Kumar Karlapu, Deputy Secretary, Department of Health and Family Welfare issued the circular regarding the extension of DCGI for a further period of three months.
The DCGI heads the Central Drugs Standard Control Organisation (CDSCO) which is responsible for ensuring quality drug supply across the country. It also has the authority to approve new drugs and regulate clinical trials.
Read also: Dr VG Somani to hold charge of DCGI post for another 3 months
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd